SPRY

ARS Pharmaceuticals Inc

May 15 • 04:00PM ET

7.43

-0.51 -6.49 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: COGT ARQT TRVI CABA AUPH

| Held by: XBI VTI IWM VXF IWO IBB SCHA VTWO SMLF VHT

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-2.00	Insider Own	36.94%	Shs Outstand	99.30M	Perf Week	-15.05%
Market Cap	737.28M	Forward P/E	-	EPS next Y	-0.91	Insider Trans	0.00%	Shs Float	62.62M	Perf Month	-9.23%
Enterprise Value	633.42M	PEG	-	EPS next Q	-0.47	Inst Own	73.49%	Short Float	41.83%	Perf Quarter	-16.10%
Income	-197.98M	P/S	7.45	EPS this Y	1.26%	Inst Trans	-0.31%	Short Ratio	17.51	Perf Half Y	-16.99%
Sales	98.99M	P/B	12.03	EPS next Y	47.15%	ROA	-64.39%	Short Interest	26.19M	Perf YTD	-36.27%
Book/sh	0.62	P/C	3.67	EPS next 5Y	-	ROE	-136.40%	52W High	18.90 -60.71%	Perf Year	-39.11%
Cash/sh	2.02	P/FCF	-	EPS past 3/5Y	-26.04% -12.85%	ROIC	-125.44%	52W Low	6.66 11.49%	Perf 3Y	-4.93%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	300.09% -	Gross Margin	74.12%	Volatility	7.94% 6.18%	Perf 5Y	-72.00%
Dividend TTM	-	EV/Sales	6.40	EPS Y/Y TTM	-1130.30%	Oper. Margin	-204.49%	ATR (14)	0.53	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	4.77	Sales Y/Y TTM	1.92%	Profit Margin	-200.00%	RSI (14)	35.21	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	4.94	EPS Q/Q	-76.39%	SMA20	-11.10%	Beta	0.90	Target Price	26.00
Payout	-	Debt/Eq	1.58	Sales Q/Q	184.47%	SMA50	-10.52%	Rel Volume	2.45	Prev Close	7.94
Employees	163	LT Debt/Eq	1.57	Earnings	May 15 BMO	SMA200	-26.51%	Avg Volume	1.50M	Price	7.43
IPO	Dec 04, 2020	Option/Short	Yes / Yes	EPS/Sales Surpr.	-18.22% 2.17%	Trades		Volume	3,671,386	Change	-6.49%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)